Cargando…

Cost-effectiveness of early goal-directed therapy in the treatment of severe sepsis and septic shock

Detalles Bibliográficos
Autores principales:	Huang, DT, Angus, DC, Dremsizov, TT, Rivers, EP, Clermont, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301677/ http://dx.doi.org/10.1186/cc2121

Ejemplares similares

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

An upper estimate of the attributable mortality and cost of severe sepsis in surgical patients
por: Linde-Zwirble, WT, et al.
Publicado: (2003)

Prognostic value of the bone marrow in severe sepsis/septic shock
por: Milheiro, R, et al.
Publicado: (1999)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Phagocytosis of granulocytes is decreased in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2000)

Acidosis and mortality in severe sepsis and septic shock evaluated by base excess variation
por: Palma, LC, et al.
Publicado: (2003)

How well does TOKS identify patients with severe sepsis or septic shock?
por: Tanderup, Anette, et al.
Publicado: (2013)

Impact of socioeconomic status on mortality and morbidity in patients with severe sepsis and septic shock
por: Schnegelsberg, Amal, et al.
Publicado: (2015)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

C5a receptor expression on leukocytes from patients with severe sepsis or septic shock
por: Furebring, M, et al.
Publicado: (2001)

Comparing Gray's and Cox models in sepsis survival
por: Kasal, J, et al.
Publicado: (2001)

Arterio- and veno-venosus hemofiltration in the treatment of sepsis and septic shock
por: Marjanek, Zs, et al.
Publicado: (2002)

Mobilization of leukocytes in patients with severe sepsis and septic shock is associated with increased apoptosis, as detected by Annexin V binding
por: Weiss, M, et al.
Publicado: (2001)

“Early goal-directed therapy” versus “Early” and “goal-directed” therapy for severe sepsis and septic shock: Time to rationalize
por: Dhooria, Sahajal, et al.
Publicado: (2015)

Peaks in G-CSF serum concentrations are accompanied by an increase in phagocytotic activity in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2001)

Severity stratification of septic shock according to noradrenaline requirement
por: Hernández, G, et al.
Publicado: (2001)

Severity stratification of septic shock according to noradrenaline requirement
por: Hernández, G, et al.
Publicado: (2001)

The IL-10 -819T polymorphism is associated with increased susceptibility to severe sepsis
por: Wood, KA, et al.
Publicado: (2003)

Initial plasma levels of lipopolysaccharide binding protein are associated with severe sepsis in patients with community-acquired pneumonia
por: Martino, ML, et al.
Publicado: (2003)

The outcome of patients presenting to the emergency department with severe sepsis or septic shock
por: Rivers, Emanuel
Publicado: (2006)

Usefulness of intrathoracic blood volume in the early phase of hemodynamic instability of patients with sepsis or septic shock
por: Sakka, SG, et al.
Publicado: (1999)

Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE
por: Nguyen, H. Bryant, et al.
Publicado: (2016)

Sublingual leukocyte activation in patients with severe sepsis or septic shock
por: Fabian-Jessing, BK, et al.
Publicado: (2015)

Cost-effectiveness of a rapid and accurate test for diagnosing infection in severe sepsis and septic shock patients
por: Walke, T, et al.
Publicado: (2010)

Preload assessment in septic shock
por: Donati, A, et al.
Publicado: (2000)

Hypocalcemia in children with septic shock
por: Buysse, CMP, et al.
Publicado: (2001)

Direct intensive care costs of severe sepsis and septic shock patients in Thailand
por: Khwannimit, B, et al.
Publicado: (2015)

658. Cost-effectiveness of Molecular Diagnostic Assays for the Therapy of Severe Sepsis and Septic Shock in the Emergency Department
por: Zacharioudakis, Ioannis, et al.
Publicado: (2019)

Early goal directed therapy for sepsis and septic shock: collaborative implementation models
por: Baram, M, et al.
Publicado: (2004)

Effect of myocardial preservation of early goal-directed therapy on severe sepsis/septic shock patients in the ICU
por: Cai, GL, et al.
Publicado: (2010)

Procalcitonin serum concentrations do not differentiate severity of septic shock in postoperative patients
por: Weiss, M, et al.
Publicado: (2000)

Norepinephrine requirement is not an independent variable to predict outcome in severe septic shock patients
por: Silva, E, et al.
Publicado: (2002)

Myocardial cell injury in septic shock
por: Rodrigues, MG, et al.
Publicado: (2003)

Mortality reduction in patients with severe sepsis and septic shock through a comprehensive sepsis initiative
por: Nguyen, K, et al.
Publicado: (2014)

Compliance with vasopressor use of early goal-directed therapy is not associated with decreased mortality in severe sepsis/septic shock
por: Afessa, Bekele, et al.
Publicado: (2008)

Meta-analysis of Protocolized Goal-Directed Hemodynamic Optimization for the Management of Severe Sepsis and Septic Shock in the Emergency Department
por: Wira, Charles R., et al.
Publicado: (2014)

Terlipressin in the treatment of catecholamine resistant septic shock
por: Auzinger, GM, et al.
Publicado: (2002)

Septic shock etiology in kidney transplant recipients
por: De Marco, FVC, et al.
Publicado: (2002)

Determinants of natriuretic peptides in early septic shock
por: Witthaut, R, et al.
Publicado: (1998)

The effect of different chloride concentrations in intravenous fluids on patient outcomes
por: Hartman, ME, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_adancu9vpb317np7nvhtqbg1gm